Clinical Trials Directory

Trials / Completed

CompletedNCT06467487

Electronic Health Record Strategies to Promote Diverse Participation in Research AIM 2

Leveraging Community Engagement and Electronic Health Record Strategies to Promote Diverse Participation in COVID-19 Clinical Trials -2

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
214,526 (actual)
Sponsor
Yale University · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

Based on the outcomes of the initial study (NCT05348603), this optimization study will employ the most effective interventions (letters and messages) and distribute these communications to underrepresented minorities to further promote interest in research. Optimized language will be distributed in English, Spanish, Portuguese, Chinese, Arabic, or Haitian Creole, based on preferred language identified in the patient profile in an electronic medical records system.

Detailed description

The primary objective of the optimization study is to examine the effectiveness on increasing interest in research of an optimized letter versus a generic letter; an optimized message versus a generic message; and an optimized letter and an optimized message versus a generic letter and a generic message. The secondary objective of the optimization study is to examine the effectiveness on increasing participation in research of an optimized letter versus a generic letter, an optimized message versus a generic message, an optimized letter and an optimized message versus a generic letter and a generic message.

Conditions

Interventions

TypeNameDescription
OTHERTraditional LetterPatients receive a traditional letter.
OTHERDirect to Patient MessagePatients receive a direct to patient message via the portal.
OTHEROptimized LetterPatients receive an optimized letter.
OTHERDirect to Patient Message - OptimizedPatients receive an optimized direct to patient message via the portal.

Timeline

Start date
2024-09-04
Primary completion
2025-01-06
Completion
2025-01-06
First posted
2024-06-21
Last updated
2025-01-13

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT06467487. Inclusion in this directory is not an endorsement.